NASDAQ:NUZE NuZee (NUZE) Stock Price, News & Analysis → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free NUZE Stock Alerts $2.15 +0.08 (+3.97%) (As of 01:17 PM ET) Add Compare Share Share Today's Range$1.85▼$2.2750-Day Range$1.17▼$2.0752-Week Range$1.13▼$13.00Volume689,310 shsAverage Volume379,607 shsMarket Capitalization$2.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get NuZee alerts: Email Address Ad Unstoppable ProsperityRSVP: Charles Payne’s Cash Flow WorkshopAre you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.Register For Free Now! About NuZee Stock (NASDAQ:NUZE)NuZee, Inc., together with its subsidiaries, manufactures, packs, and sells single-serve pour-over coffee and tea bag-style coffee for coffee roasters and food service companies in North America and South Korea. The company sells its products under Coffee Blenders, Twin Peaks, DRIPKIT, and Stone Brewing brand names. NuZee, Inc. was incorporated in 2011 and is headquartered in Vista, California.Read More NUZE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUZE Stock News HeadlinesMay 7, 2024 | americanbankingnews.comNuZee (NASDAQ:NUZE) Shares Down 10.6% May 6, 2024 | investorplace.comNUZE Stock Earnings: Nuzee Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.May 2, 2024 | finance.yahoo.comNuZee, Inc. Announces Completion of Private Placement of Convertible Note and WarrantsMay 2, 2024 | prnewswire.comNuZee, Inc. Announces Completion of Private Placement of Convertible Note and WarrantsApril 14, 2024 | finance.yahoo.comHot Drinks Packaging Market Size is projected to reach USD 16.10 billion by 2031, growing at a CAGR of 4.12%: Straits ResearchApril 11, 2024 | prnewswire.comNuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)March 1, 2024 | finanznachrichten.deNuZee, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)May 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.February 29, 2024 | prnewswire.comNuZee, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)February 27, 2024 | finance.yahoo.comBTDR Apr 2024 2.500 putFebruary 14, 2024 | finance.yahoo.comNuZee, Inc. Announces Extension for Filing of Form 10-QFebruary 14, 2024 | prnewswire.comNuZee, Inc. Announces Extension for Filing of Form 10-QJanuary 26, 2024 | finance.yahoo.comNuZee, Inc. Announces Receipt of NASDAQ NotificationJanuary 17, 2024 | finance.yahoo.comNuZee, Inc. Reports Full-Year Fiscal 2023 Financial ResultsDecember 29, 2023 | finance.yahoo.comNuZee, Inc. Announces Delay in Filing Form 10-KDecember 13, 2023 | msn.comStocks Tread Water Before the Open as Fed Rate Decision Looms, U.S. PPI Data in FocusDecember 13, 2023 | msn.comStocks Tread Water Before the Open as Investors Await Fed Rate Decision and U.S. PPI DataDecember 12, 2023 | marketwatch.comNuZee Names CFO Randell Weaver President, chief operating officer.December 12, 2023 | finance.yahoo.comNuZee, Inc. Appoints Randell Weaver as President and Chief Operating OfficerDecember 5, 2023 | finance.yahoo.comNuZee, Inc. Announces Full Exercise and Closing of Over-Allotment Option in Connection with its Underwritten Public OfferingOctober 20, 2023 | finance.yahoo.comNuZee Announces Closing of $1.275 Million Underwritten Public Offering of Common StockOctober 18, 2023 | benzinga.comWhy NuZee Stock Is Down Over 40% WednesdayOctober 18, 2023 | marketwatch.comNuZee Shares Slide to 52-Week Low After Offering PricedOctober 18, 2023 | marketwatch.comNuZee Shares Slide Premarket on Planned Public OfferingOctober 18, 2023 | msn.comNuZee stock plummets on pricing of $1.275M common stock offeringOctober 18, 2023 | finance.yahoo.comNuZee Prices $1.275 Million Underwritten Public Offering of Common StockSee More Headlines Receive NUZE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NuZee and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Next Earnings (Estimated)5/20/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Miscellaneous retail Sub-IndustryN/A Current SymbolNASDAQ:NUZE CUSIPN/A CIK1527613 Webwww.mynuzee.com Phone(760) 295-2408FaxN/AEmployees33Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($11.99) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,750,000.00 Net Margins-261.24% Pretax Margin-261.24% Return on Equity-177.50% Return on Assets-121.95% Debt Debt-to-Equity RatioN/A Current Ratio1.32 Quick Ratio0.93 Sales & Book Value Annual Sales$3.35 million Price / Sales0.82 Cash FlowN/A Price / Cash FlowN/A Book Value$1.39 per share Price / Book1.55Miscellaneous Outstanding Shares1,280,000Free Float929,000Market Cap$2.76 million OptionableNot Optionable Beta1.51 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Masateru Higashida (Age 53)Chairman, CEO ,Treasurer & Secretary Comp: $300kMr. Randell L. Weaver (Age 66)President, COO & CFO Ms. Shana Bowman (Age 47)Controller Key CompetitorsAgriFORCE Growing SystemsNASDAQ:AGRIBlue Star FoodsNASDAQ:BSFCGreenlaneNASDAQ:GNLNInspire Veterinary PartnersNASDAQ:IVPN2OFFNASDAQ:NITOView All CompetitorsInsiders & InstitutionsBard Associates Inc.Bought 117,750 shares on 2/13/2024Ownership: 9.199%Masateru HigashidaSold 500 sharesTotal: $2,580.00 ($5.16/share)Masateru HigashidaSold 1,200 sharesTotal: $8,796.00 ($7.33/share)View All Insider TransactionsView All Institutional Transactions NUZE Stock Analysis - Frequently Asked Questions Should I buy or sell NuZee stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NuZee in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NUZE shares. View NUZE analyst ratings or view top-rated stocks. How have NUZE shares performed in 2024? NuZee's stock was trading at $2.54 on January 1st, 2024. Since then, NUZE shares have decreased by 15.3% and is now trading at $2.1522. View the best growth stocks for 2024 here. When is NuZee's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NUZE earnings forecast. When did NuZee's stock split? Shares of NuZee reverse split on Thursday, December 29th 2022. The 1-35 reverse split was announced on Thursday, December 29th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of NuZee own? Based on aggregate information from My MarketBeat watchlists, some companies that other NuZee investors own include Adaptimmune Therapeutics (ADAP), Acasti Pharma (ACST), Acorda Therapeutics (ACOR), ACI Worldwide (ACIW), Albertsons Companies (ACI), Achieve Life Sciences (ACHV), Acer Therapeutics (ACER), Abiomed (ABMD) and ARCA biopharma (ABIO). How do I buy shares of NuZee? Shares of NUZE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NUZE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuZee, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
